Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 39:21 30 Years Fighting for Every Future: Opening Remarks from Pat Furlong – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 1:53:29 Navigating the Approved Therapy Landscape – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 41:45 Outcome Measures: The Eras Tour – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 24:43 Community Conversation With Pfizer – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 27:49 Building Your Community: It Takes a Team – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 32:41 Keynote: A Reflection on Progress and Hope – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 45:06 How Managing Behaviors Impacts Your Quality of Life – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 1:21:41 Research Row: Strategies to Restore Dystrophin – PPMD 2024 Annual Conference 5 months ago 2024 PPMD Annual Conference,Conferences & Meetings 123…25»Page 1 of 25
by: Parent Project Muscular Dystrophy
